· Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required)
(PAR-21-129)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
(PAR-21-130)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
· Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)
(PAR-21-131)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
(PAR-21-132)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
(PAR-21-133)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
· Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
(PAR-21-134)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
(PAR-21-135)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
(PAR-21-136)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
(PAR-21-137)
National Institute of Mental Health
Application Receipt Date(s): June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
· AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)
(PAR-21-141)
National Institute on Aging
Application Receipt Date(s): May 25, 2021; May 25, 2022; May 25, 2023
· NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
(PAR-21-160)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): June 08, 2021
· Limited Competition: NEI – DOD Vision Research Collaborative (R01 Clinical Trial Optional)
(PAR-21-161)
National Eye Institute
Application Receipt Date(s): April 22, 2021
· Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional)
(PAR-21-191)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
Office of Disease Prevention
Office of Research on Women’s Health
Application Receipt Date(s): April 30, 2021, All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
· Firearm Injury and Mortality Prevention Research (R01Clinical Trial Optional)
(PAR-21-192)
Office of Behavioral and Social Sciences Research
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Disease Prevention
Office of Research on Women’s Health
Application Receipt Date(s): April 30, 2021, All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
· NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
(PAR-21-193)
National Institute for Occupational Safety and Health
Application Receipt Date(s): Standard dates apply; All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
· Triadic Interactions in Clinical Encounters Involving People with Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD), Clinicians, and Care Partners (R01 Clinical Trial Optional)
(RFA-AG-22-020)
National Institute on Aging
Application Receipt Date(s): June 23, 2021
· Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed)
(RFA-AI-21-004)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 18, 2021
· Tropical Medicine Research Centers Coordinating Center (U01 Clinical Trial Not Allowed)
(RFA-AI-21-005)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 18, 2021
· Data Standards for Tobacco Research and Scientific Review Program (U24) Clinical Trial Not Allowed
(RFA-FD-22-002)
Food and Drug Administration
Application Receipt Date(s): June 1, 2021, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
